Skip to main content
Top
Published in: Digestive Diseases and Sciences 3/2019

01-03-2019 | Acute Pancreatitis | Editorial

Do Elevated Triglycerides Truly Trigger Acute Pancreatitis?

Authors: Mahya Faghih, Vikesh K. Singh

Published in: Digestive Diseases and Sciences | Issue 3/2019

Login to get access

Excerpt

Hypertriglyceridemia, the third most common cause of acute pancreatitis (AP) in the USA, has recently been reported to be the most common cause of AP in China [1]. There is an increased risk of severe acute pancreatitis in patients with hypertriglyceridemic AP, with a recent prospective study using trend analysis across patients with normal (< 150 mg/dL) to severe (≥ 1000 mg/dL) TG levels reporting significantly higher rates of persistent organ failure, need for ICU care, and longer length of hospital stay with rising triglyceride levels [2]. While a TG level of ≥ 1000 mg/dL is considered the threshold at which the risk of AP increases, the absolute risk is still low at 5%, which modestly increases to 10–20% in patients with TG levels > 2000 mg/dL [3]. Nonetheless, the risk of AP is not negligible at lower TG levels; a large epidemiologic study from Denmark reported increased risk of AP starting when TG levels were > 177 mg/dL (HR 2.3; 95% CI 1.3–4.0) that linearly increased to a HR 7.7; 95% CI 3–19.8 when TG levels were > 443 mg/dL [4, 5]. …
Literature
1.
go back to reference Zhu Y, Pan X, Zeng H, et al. A study on the etiology, severity, and mortality of 3260 patients with acute pancreatitis according to the Revised Atlanta Classification in Jiangxi, China over an 8-year period. Pancreas. 2017;46:504–509.CrossRefPubMed Zhu Y, Pan X, Zeng H, et al. A study on the etiology, severity, and mortality of 3260 patients with acute pancreatitis according to the Revised Atlanta Classification in Jiangxi, China over an 8-year period. Pancreas. 2017;46:504–509.CrossRefPubMed
2.
go back to reference Nawaz H, Koutroumpakis E, Easler J, et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am J Gastroenterol. 2015;110:1497–1503.CrossRefPubMed Nawaz H, Koutroumpakis E, Easler J, et al. Elevated serum triglycerides are independently associated with persistent organ failure in acute pancreatitis. Am J Gastroenterol. 2015;110:1497–1503.CrossRefPubMed
4.
go back to reference Hansen SEJ, Madsen CM, Varbo A, Nordestgaard BRG. Low-grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis: a study of more than 115,000 individuals from the general population. Clin Chem. 2018;65:321–332.CrossRefPubMed Hansen SEJ, Madsen CM, Varbo A, Nordestgaard BRG. Low-grade inflammation in the association between mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis: a study of more than 115,000 individuals from the general population. Clin Chem. 2018;65:321–332.CrossRefPubMed
5.
go back to reference Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Int Med. 2016;176:1834–1842.CrossRef Pedersen SB, Langsted A, Nordestgaard BG. Nonfasting mild-to-moderate hypertriglyceridemia and risk of acute pancreatitis. JAMA Int Med. 2016;176:1834–1842.CrossRef
6.
go back to reference Christian JB, Bourgeois N, Snipes R, Lowe KA. Prevalence of severe (500 to 2000 mg/dl) hypertriglyceridemia in United States adults. Am J Cardiol. 2011;107:891–897.CrossRefPubMed Christian JB, Bourgeois N, Snipes R, Lowe KA. Prevalence of severe (500 to 2000 mg/dl) hypertriglyceridemia in United States adults. Am J Cardiol. 2011;107:891–897.CrossRefPubMed
7.
go back to reference Hegele RA, Ginsberg HN, Chapman MJ, et al. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol. 2014;2:655–666.CrossRefPubMed Hegele RA, Ginsberg HN, Chapman MJ, et al. The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. Lancet Diabetes Endocrinol. 2014;2:655–666.CrossRefPubMed
8.
go back to reference Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med. 2009;169:1035–1045.CrossRefPubMed Yadav D, Hawes RH, Brand RE, et al. Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med. 2009;169:1035–1045.CrossRefPubMed
9.
go back to reference Majumder S, Gierisch JM, Bastian LA. The association of smoking and acute pancreatitis: a systematic review and meta-analysis. Pancreas. 2015;44:540–546.CrossRefPubMed Majumder S, Gierisch JM, Bastian LA. The association of smoking and acute pancreatitis: a systematic review and meta-analysis. Pancreas. 2015;44:540–546.CrossRefPubMed
10.
go back to reference Ooi CY, Dorfman R, Cipolli M, et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology. 2011;140:153–161.CrossRefPubMed Ooi CY, Dorfman R, Cipolli M, et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology. 2011;140:153–161.CrossRefPubMed
11.
go back to reference Di Leo M, Bianco M, Zuppardo RA, et al. Meta-analysis of the impact of SPINK1 p.N34S gene variation in Caucasic patients with chronic pancreatitis. An update. Dig Liver Dis. 2017;49:847–853.CrossRefPubMed Di Leo M, Bianco M, Zuppardo RA, et al. Meta-analysis of the impact of SPINK1 p.N34S gene variation in Caucasic patients with chronic pancreatitis. An update. Dig Liver Dis. 2017;49:847–853.CrossRefPubMed
12.
go back to reference Derikx MH, Kovacs P, Scholz M, et al. Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study. Gut. 2015;64:1426–1433.CrossRefPubMed Derikx MH, Kovacs P, Scholz M, et al. Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study. Gut. 2015;64:1426–1433.CrossRefPubMed
14.
go back to reference Driver SL, Martin SS, Gluckman TJ, Clary JM, Blumenthal RS, Stone NJ. Fasting or nonfasting lipid measurements: it depends on the question. J Am Coll Cardiol. 2016;67:1227–1234.CrossRefPubMed Driver SL, Martin SS, Gluckman TJ, Clary JM, Blumenthal RS, Stone NJ. Fasting or nonfasting lipid measurements: it depends on the question. J Am Coll Cardiol. 2016;67:1227–1234.CrossRefPubMed
15.
go back to reference Gaudet D, Alexander VJ, Baker BF, et al. Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia. N Engl J Med. 2015;373:438–447.CrossRefPubMed Gaudet D, Alexander VJ, Baker BF, et al. Antisense inhibition of apolipoprotein C-III in patients with hypertriglyceridemia. N Engl J Med. 2015;373:438–447.CrossRefPubMed
Metadata
Title
Do Elevated Triglycerides Truly Trigger Acute Pancreatitis?
Authors
Mahya Faghih
Vikesh K. Singh
Publication date
01-03-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 3/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05501-0

Other articles of this Issue 3/2019

Digestive Diseases and Sciences 3/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.